April 2, 2014—Stakeholders will have 60 days to comment on the proposed 340B “mega-reg” that is still on track to be published in June, Office of Pharmacy Affairs Director Cmdr. Krista Pedley said at a drug industry conference last week.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)